Happy Friday Zingernation! If you don’t succeed, try again. Andrew Left of Citron research took that saying to heart, and went short GameStop this week after getting crushed on the trade in 2021. But so far, this time, it appears to be working out for Mr. Left.

-Aaron Bry and Nic Chahine

Plus, check out the company that’s using cannabinoids to treat Alzheimer’s.

Also, have you seen this new way to trade options using the "MoneyLine" approach? It's a way to win at 3X the rate of every options trader. See the strategy here.

MARKET SNAPSHOT

Yesterday: The Dow hit $40k for the first time in its history, but a late-day sell off took us off the highs of the day.

On Our Radar: Options expiration day! The May monthlies will expire today, adding extra volatility to the market. Buckle up!

Plus: 20-year options trading pro Nic Chahine releases his top options trade each week. The secret is the "MoneyLine." Get the details HERE.

TOP STORY

JPMorgan's Jamie Dimon Warns Of 'A Lot Of Inflationary Forces' Ahead

In Short: Jamie Dimon, the CEO of JPMorgan Chase & Co, has voiced concerns about the persistent inflationary pressures in the U.S. economy. He suggests that these pressures may lead to a prolonged period of higher interest rates than what investors anticipate.

What Happened: Dimon, highlighted the various factors contributing to the ongoing inflation. These include costs associated with the green economy, re-militarization, infrastructure spending, and substantial fiscal deficits. He also pointed out that geopolitical factors could significantly influence the economy in the coming year. Dimon said this in an interview with Bloomberg Television on Thursday.

Quoted: "A lot of inflationary forces are in front of us," Dimon said.

So: Dimon has been consistently warning about the possibility of inflation being more persistent than what most investors expect. In his annual letter to shareholders, he mentioned that JPMorgan Chase & Co. is prepared for interest rates ranging from 2% to 8% or even higher.

Click here to read the full story.

PRESENTED BY INMED

InMed (NASDAQ: INM) Developing Cannabinoids Analogs To Treat Alzheimer's – New Studies Showcase INM-901's Therapeutic Abilities

Nearly 7 million Americans suffer from Alzheimer's and that’s poised to grow to 13 million by 2050. There are several treatments on the market, but they focus on addressing the symptoms rather than repairing and regenerating the damaged neurons. Some drugs and treatments may slow the progression of cognitive decline, but none can reverse the effects of Alzheimer’s. That’s where InMed Pharmaceuticals Inc. (NASDAQ: INM) comes in. The leader in cannabinoid and cannabinoid analogs pharmaceutical research, development, manufacturing and commercialization has identified a rare cannabinoid to treat Alzheimer’s.

Named INM-901 and based on early preclinical research, the cannabinoid analog showed the potential to target several biological pathways associated with Alzheimer’s, providing neuroprotection to the brain neurons and improving neuronal function. That’s potentially big news given the costs associated with treating Alzheimer's and dementia are projected to swell to $1 trillion by 2050 from $360 billion today. To learn more about InMed’s promising INM-901 treatment click here.

Click here to learn more.

FIVE ZINGERS

r/AI: Reddit announced a new partnership with ChatGPT parent company OpenAI and now the stock is soaring.

Heating Up: NVIDIA has been the darling of the market when it comes to AI. But now, competition might be heating up.

The Theme Is Meme: The meme stock rally might be running out of steam, but here’s why today’s price action will be a huge test for the group.

Bottoms Up: Has China bottomed? Here’s why billionaire investors like David Tepper are piling back into Chinese names.

Ganging Up: Netflix is joining other companies like Disney to demand better deals from Apple’s app store. 

MONEYLINE UNVEILED

My $79 Bet With You

The What: Nic Chahine reveals his 83% win-rate secret. This same secret has also delivered an average win rate of 27%--that’s accounting for both winners AND losers… But he's used it to uncover trades that yielded as much as $140 for users in mere hours… And it’s pointed members to gains as high as 411% in just a few short weeks.

Why It Matters: Remember… the vaunted research firm DALBAR has proved that the average investor is lucky to make more than 7.13% in a full year. Of course, that’s just his average gain. As you’ve seen, a handful are much higher.

Unparalleled Results: Nic is ready to guide you to trade options better. Because most people have no clue how to trade options profitably. He's winning double, even triple the rate of others because he does things differently. You could have him guiding you along the way to discover how to make trades like:

411% on AXP in 31 days

123% on BX in 17 days

102% on RIVN in 4 months

The "Bet" That Could Change Your Life: Let's not over-complicate this. It's really this simple. Access Nic's 83% win-rate method for a full 12 months for just $79. That’s barely twenty cents a day… Why so cheap?

So: Well, he knows that you need to try his work first, to see if it’s right for you. A lot of people just assume that options are too complicated for them to trade—even though that couldn’t be further from the truth. And to make your decision even easier, today he's including a 12-month guarantee (something he has NEVER done before).

Don't miss out: Get a sneak peek at Nic Chahine's $79 "bet" & 83% win-rate secret here.